Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
22.54
+1.34 (6.32%)
At close: Mar 27, 2026

HKG:1877 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
2,6152,5023,7885,9973,507
Short-Term Investments
---17.93-
Trading Asset Securities
600.78430.51---
Cash & Short-Term Investments
3,2162,9333,7886,0153,507
Cash Growth
9.65%-22.58%-37.02%71.53%3.59%
Accounts Receivable
506.75509.82483.23232.731,301
Other Receivables
-36.44374.0178.8128.05
Receivables
506.75546.26857.23314.251,329
Inventory
573.11584.47538.05599.02484.6
Prepaid Expenses
---239.82-
Other Current Assets
162.01220.38387.5936.94524.79
Total Current Assets
4,4584,2845,5717,2055,845
Property, Plant & Equipment
4,8724,1953,8093,2782,801
Long-Term Investments
1,9141,2261,1331,2921,485
Other Intangible Assets
559.77521.41546.9698.91264.98
Long-Term Deferred Tax Assets
88.3187.05103.4228.4388.55
Long-Term Deferred Charges
9.766.1212.6-27.79
Other Long-Term Assets
480.35461.94167.14473.39522.34
Total Assets
12,38210,78211,34312,57611,035
Accounts Payable
73.99115.9125.19370.2363.17
Accrued Expenses
804.98901.441,046917.211,603
Short-Term Debt
603.2678.11452.44391.75-
Current Portion of Long-Term Debt
659.39216.586.96-10.6
Current Portion of Leases
32.0130.2935.9343.6634.47
Current Income Taxes Payable
4.7612.4117.98-63.08
Current Unearned Revenue
22.188.17146.30.4445.8
Other Current Liabilities
577.77531.11527.9250.96181.59
Total Current Liabilities
2,7782,4942,4381,7742,001
Long-Term Debt
2,7941,9801,196839.58490
Long-Term Leases
56.6226.3117.4546.5993.13
Long-Term Unearned Revenue
167.17181.91183.46121.62122.46
Other Long-Term Liabilities
530.06168187.15-11.5
Total Liabilities
6,3264,8504,0222,7822,719
Common Stock
1,027985.69985.69982.87910.76
Additional Paid-In Capital
16,41715,40715,395-11,423
Retained Earnings
-11,216-10,341-9,060--4,389
Treasury Stock
-30.89-30.89-26.89--
Comprehensive Income & Other
-166.69-159.94-142.078,5190.21
Total Common Equity
6,0305,8607,1519,5017,945
Minority Interest
26.1671.71169.39292.83371.28
Shareholders' Equity
6,0575,9327,3219,7948,316
Total Liabilities & Equity
12,38210,78211,34312,57611,035
Total Debt
4,1452,9311,7891,322628.19
Net Cash (Debt)
-928.981.822,0004,6932,878
Net Cash Growth
--99.91%-57.39%63.05%13.58%
Net Cash Per Share
-0.920.002.035.123.23
Filing Date Shares Outstanding
1,026984.87985.01982.87910.76
Total Common Shares Outstanding
1,026984.87985.01982.87910.76
Working Capital
1,6791,7903,1335,4313,843
Book Value Per Share
5.885.957.269.678.72
Tangible Book Value
5,4715,3396,6049,4037,680
Tangible Book Value Per Share
5.335.426.709.578.43
Buildings
1,4251,3791,419-891.83
Machinery
2,1612,0221,9211,5221,419
Construction In Progress
2,5721,8591,3251,048801.93
Leasehold Improvements
---65.57-
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.